Abstract
Oxidative stress and inflammation are two of the most critical factors implicated in carcinogenesis and other degenerative disorders. We have investigated how lunasin, a known anti-cancer seed peptide, affect these factors. This peptide inhibits linoleic acid oxidation and acts as 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical scavenger. Furthermore, using LPS-stimulated RAW 264.7 macrophages, we have demonstrated that lunasin reduces, in a significant dose-dependent manner, the production of reactive oxygen species (ROS) by LPS-induced macrophages. Lunasin also inhibits the release of pro-inflammatory cytokines (tumor necrosis factor-α [TNF-α] and interleukine-6 [IL-6]). On the basis of these potent antioxidant and anti-inflammatory properties, we propose lunasin not only as a cancer preventive and therapeutic agent but also as an agent against other inflammatory-related disorders.
| Original language | English |
|---|---|
| Pages (from-to) | 803-808 |
| Number of pages | 6 |
| Journal | Biochemical and Biophysical Research Communications |
| Volume | 390 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2009 Dec 18 |
Fingerprint
Keywords
- Anti-inflammatory activity
- Antioxidant activity
- Lunasin
- Macrophages
ASJC Scopus subject areas
- Biophysics
- Biochemistry
- Molecular Biology
- Cell Biology
Cite this
Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. / Hernández-Ledesma, Blanca; Hsieh, Chia Chien; de Lumen, Ben O.
In: Biochemical and Biophysical Research Communications, Vol. 390, No. 3, 18.12.2009, p. 803-808.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages
AU - Hernández-Ledesma, Blanca
AU - Hsieh, Chia Chien
AU - de Lumen, Ben O.
PY - 2009/12/18
Y1 - 2009/12/18
N2 - Oxidative stress and inflammation are two of the most critical factors implicated in carcinogenesis and other degenerative disorders. We have investigated how lunasin, a known anti-cancer seed peptide, affect these factors. This peptide inhibits linoleic acid oxidation and acts as 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical scavenger. Furthermore, using LPS-stimulated RAW 264.7 macrophages, we have demonstrated that lunasin reduces, in a significant dose-dependent manner, the production of reactive oxygen species (ROS) by LPS-induced macrophages. Lunasin also inhibits the release of pro-inflammatory cytokines (tumor necrosis factor-α [TNF-α] and interleukine-6 [IL-6]). On the basis of these potent antioxidant and anti-inflammatory properties, we propose lunasin not only as a cancer preventive and therapeutic agent but also as an agent against other inflammatory-related disorders.
AB - Oxidative stress and inflammation are two of the most critical factors implicated in carcinogenesis and other degenerative disorders. We have investigated how lunasin, a known anti-cancer seed peptide, affect these factors. This peptide inhibits linoleic acid oxidation and acts as 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical scavenger. Furthermore, using LPS-stimulated RAW 264.7 macrophages, we have demonstrated that lunasin reduces, in a significant dose-dependent manner, the production of reactive oxygen species (ROS) by LPS-induced macrophages. Lunasin also inhibits the release of pro-inflammatory cytokines (tumor necrosis factor-α [TNF-α] and interleukine-6 [IL-6]). On the basis of these potent antioxidant and anti-inflammatory properties, we propose lunasin not only as a cancer preventive and therapeutic agent but also as an agent against other inflammatory-related disorders.
KW - Anti-inflammatory activity
KW - Antioxidant activity
KW - Lunasin
KW - Macrophages
UR - http://www.scopus.com/inward/record.url?scp=70449697863&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449697863&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2009.10.053
DO - 10.1016/j.bbrc.2009.10.053
M3 - Article
C2 - 19836349
AN - SCOPUS:70449697863
VL - 390
SP - 803
EP - 808
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
SN - 0006-291X
IS - 3
ER -